SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverBIO
HealthcareNYQUSD

Bio-Rad Laboratories, Inc.

$001234567890012345678900123456789.0012345678900123456789+3.8%
52w low (est.) $236.50$383.52 52w high (est.)
Market data
Market cap
USD7.96B
52-week range
USD236.73 – USD343.12
Beta (vs market)
1.08
Sector
Healthcare
Data quality
92/100
Valuation
P/E ratio
49.3x
DCF fair value
USD255.37
Margin of safety
-15.2%
Forward P/E
30.6x
PEG ratio
4.01
Quality & efficiency
Moat score
45/100
Return on equity
2.5%
Profit margin
6.5%
Debt / equity
0.20
Growth & analysts
Revenue growth (YoY)
+1.1%
Analyst target
USD297.00
Target upside
-1.3%
Analysts covering
5

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Valuation

ValueGrowthProfitHealthIncome30QUALITY
Overall Rating
40
Reduce
Reduce

Derived from filed metrics · High confidence (92% of the inputs available)

Moat Score45
DCF Intrinsic Value
USD255.37-15.2% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD7.96B
P/E Ratio
49.3
Dividend Yield
0.00%
Revenue Growth
+1.1%
Profit Margin
6.5%
ROE
2.5%
Debt / Equity
0.20
Beta
1.08
vs Healthcare sector:P/E 49 vs 28 Moat 45 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · BIO